267 related articles for article (PubMed ID: 21887732)
1. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.
Ogata H; Kato J; Hirai F; Hida N; Matsui T; Matsumoto T; Koyanagi K; Hibi T
Inflamm Bowel Dis; 2012 May; 18(5):803-8. PubMed ID: 21887732
[TBL] [Abstract][Full Text] [Related]
2. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
Ogata H; Matsui T; Nakamura M; Iida M; Takazoe M; Suzuki Y; Hibi T
Gut; 2006 Sep; 55(9):1255-62. PubMed ID: 16484504
[TBL] [Abstract][Full Text] [Related]
3. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
[TBL] [Abstract][Full Text] [Related]
4. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
5. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Herfarth H; Barnes EL; Valentine JF; Hanson J; Higgins PDR; Isaacs KL; Jackson S; Osterman MT; Anton K; Ivanova A; Long MD; Martin C; Sandler RS; Abraham B; Cross RK; Dryden G; Fischer M; Harlan W; Levy C; McCabe R; Polyak S; Saha S; Williams E; Yajnik V; Serrano J; Sands BE; Lewis JD;
Gastroenterology; 2018 Oct; 155(4):1098-1108.e9. PubMed ID: 29964043
[TBL] [Abstract][Full Text] [Related]
11. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
[TBL] [Abstract][Full Text] [Related]
12. EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Lasa J; Olivera P
Arq Gastroenterol; 2017; 54(2):167-172. PubMed ID: 28327826
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.
Kawakami K; Inoue T; Murano M; Narabayashi K; Nouda S; Ishida K; Abe Y; Nogami K; Hida N; Yamagami H; Watanabe K; Umegaki E; Nakamura S; Arakawa T; Higuchi K
World J Gastroenterol; 2015 Feb; 21(6):1880-6. PubMed ID: 25684955
[TBL] [Abstract][Full Text] [Related]
14. Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis.
Olmedo Martín RV; Amo Trillo V; González Grande R; Jiménez Pérez M
Rev Esp Enferm Dig; 2017 Aug; 109(8):559-565. PubMed ID: 28617029
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy.
Inoue T; Murano M; Narabayashi K; Okada T; Nouda S; Ishida K; Kawakami K; Abe Y; Takeuchi T; Tokioka S; Umegaki E; Higuchi K
Intern Med; 2013; 52(1):15-20. PubMed ID: 23291669
[TBL] [Abstract][Full Text] [Related]
16. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
[TBL] [Abstract][Full Text] [Related]
18. Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases.
Kawamura H; Matsumoto S; Nakamura N; Miyatani H; Mashima H
Am J Case Rep; 2017 Apr; 18():405-409. PubMed ID: 28411286
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis.
Baumgart DC; Macdonald JK; Feagan B
Cochrane Database Syst Rev; 2008 Jul; (3):CD007216. PubMed ID: 18646177
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
Komaki Y; Komaki F; Micic D; Yamada A; Suzuki Y; Sakuraba A
J Gastroenterol Hepatol; 2017 Jun; 32(6):1143-1151. PubMed ID: 27957761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
